Patients with publicly sponsored insurance who were listed for liver transplantation have worse wait-list and posttransplant outcomes, as shown using the US Scientific Registry of Transplant Recipients (2001-2017).
Alita Mishra, MD
Advertisement
Articles by Alita Mishra, MD
The 3 core measures of acute myocardial infarction, congestive heart failure, and pneumonia are the leading causes of hospital admissions and expenditures. Our study sets the benchmark foundation for outcome evaluations of CMS’s value-based purchasing program and the Affordable Care Act.
Advertisement
Latest Updated Articles
- Outcomes Trends for Acute Myocardial Infarction, Congestive Heart Failure, and Pneumonia, 2005-2009
Published: January 7th 2016 | Updated:
- Outcomes of Liver Transplantation by Insurance Type in the United States
Published: April 7th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
5
